Search
Select region
Close filter
Featured Insight

London Women on Industrial Boards: Summer 2019

Hosted by Melody Meyer and Egon Zehnder, 11 board directors joined us for our third dinner for women on industrial boards. The topics spanned across ESG, diversity, and the differences between UK and US boards.

Below highlight four major themes discussed regarding industrial boards:

1. Gender Diversity

While the number of women on boards is increasing, are we losing our strongest executive talent too early? We certainly are in transition between some women 'going plural' and seeing the next generation rise up.

 


2. United States vs. United Kingdom Boards

 

3. Environmental, Social and Corporate Governance (ESG)

Do we have a greater responsibility as women on boards to advance the ESG agenda? Organizations like Chapter Zero and B-Corp are giving NEDs a language and equipping them better to explain about ESG issues. The conversation around sustainability is often led by females. Why?

"I'm deeply optimistic about the young people coming into the workforce--and wanting to change it."


4. Our Thoughts Moving Forward

We need women and men to be thinking bigger about their role in articulating - and promoting - solutions to these issues.

 

Topics Related to this Article

Related content

Ethnic Diversity: From Rapid Response to Lasting Impact

Ethnic Diversity: From Rapid Response to Lasting Impact

Diversity, Equity & Inclusion

A guide to handling difficult and sensitive topics in the workplace that will help drive progress that will move us to a more equitable… Read more

Ethical Boardroom - How a pandemic and societal pressures are altering Latin American boardrooms

Ethical Boardroom - How a pandemic and societal pressures are altering Latin American boardrooms

Board Consulting

Egon Zehnder’s 2020 Global Board Diversity Tracker, which analyses companies with a market cap of €6billion, put the number of board seats held by… Read more

“This is the Time to Shine”

“This is the Time to Shine”

Supply Chain & Operations

Biopharma supply chain leaders have the attention of the CEO and Board – now what? Read more

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top